1. Home
  2. GH vs TXRH Comparison

GH vs TXRH Comparison

Compare GH & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$110.09

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Texas Roadhouse Inc.

TXRH

Texas Roadhouse Inc.

HOLD

Current Price

$183.12

Market Cap

11.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
TXRH
Founded
2011
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.0B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
GH
TXRH
Price
$110.09
$183.12
Analyst Decision
Strong Buy
Buy
Analyst Count
21
17
Target Price
$99.48
$191.18
AVG Volume (30 Days)
1.9M
868.8K
Earning Date
02-19-2026
02-19-2026
Dividend Yield
N/A
1.51%
EPS Growth
N/A
12.56
EPS
N/A
6.55
Revenue
$902,569,000.00
$5,833,958,000.00
Revenue This Year
$35.00
$11.90
Revenue Next Year
$26.80
$10.49
P/E Ratio
N/A
$27.57
Revenue Growth
30.38
14.40
52 Week Low
$34.80
$148.73
52 Week High
$113.91
$199.99

Technical Indicators

Market Signals
Indicator
GH
TXRH
Relative Strength Index (RSI) 63.59 66.59
Support Level $106.42 $165.74
Resistance Level $113.91 $182.91
Average True Range (ATR) 3.97 3.79
MACD 0.63 1.43
Stochastic Oscillator 77.16 99.40

Price Performance

Historical Comparison
GH
TXRH

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

Share on Social Networks: